Medtronic is aggressively pursuing **tuck-in M&A** in the **low- to mid-single-digit billion-dollar range**, targeting cardiology and neuroscience to accelerate growth amid a resurgent **MedTech M&A...
A U.S. District Court ruling on January 9, 2026, has permanently halted Edwards Lifesciences' proposed $945 million to $1.2 billion acquisition of JenaValve Technology, following a Federal Trade...
Eli Lilly’s $1.2 billion all-cash acquisition of Ventyx Biosciences is a targeted move to secure a differentiated, oral NLRP3 franchise and expand its footprint across cardiometabolic,...
```html AbbVie Inc. is in advanced talks to acquire Revolution Medicines, a clinical-stage precision oncology company, in a deal valued at approximately $20 billion or more—a significant premium to...
A cannabis staffing company has accused its **CEO** of concealing ownership in a direct competitor during **merger negotiations**, potentially exposing the deal to **fiduciary duty lawsuits**,...
Alcon Inc. (NYSE: ALC) has officially terminated its $1.6 billion merger agreement with STAAR Surgical Company (NASDAQ: STAA) after STAAR shareholders rejected the deal on January 6, 2026, due to...
Hisamitsu Pharmaceutical, the Japanese maker of the iconic **Salonpas pain-relief patches**, is on the cusp of a management-led buyout valuing the company at around ¥450 billion ($2.9 billion), as...
Ingersoll Rand Inc. (NYSE: IR), a $32.5 billion industrial giant, completed the acquisition of U.S.-based lab automation specialist Scinomix, Inc. on January 5, 2026, at an attractive pre-synergy...
Samsung Biologics America (SBA), a wholly owned subsidiary of South Korea's leading contract development and manufacturing organization (CDMO), has agreed to acquire 100% of Human Genome Sciences...
